3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Interventions
Bevacizumab
13
atezolizumab
9
Specimen Handling
9
durvalumab
8
Nivolumab
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
lenvatinib
6
cabozantinib
4
Sorafenib
4
tislelizumab
3
donafenib
3
X-Rays
3
Surgical Procedures, Operative
3
Oxaliplatin
3
Ipilimumab
3
Immunotherapy
3
Fluorouracil
3
ulixertinib
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
camrelizumab
2
apatinib
2
Leucovorin
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
navitoclax
×
30 days
×
Clear all
No trials found.